Regulatory Workflows and Interactions - pharma, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/APIX---API-Exchange-for-Medicinal-Products/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
Profile: APIX Regulatory DocumentReference
identifier: Document Set Identifier/urn:uuid:924f1558-e2fe-5500-a2a2-965473e754d6, Document Version Number Identifier/urn:uuid:f8d4719d-5dd0-5787-9fd3-0471fbeb07e0
version: 1
status: Current
docStatus: Final
type: Protocol
date: 2026-09-01 10:00:00+0200
author: SynthPharma AG
description:
Clinical trial protocol WD-201, version 1.0 (synopsis).
content
Attachments
ContentType Url Size Hash Title Creation application/pdf Binary: application/pdf (3808 bytes base64) 2854 nqCrquChD2aGIetHk+fXnojGYlM=cta-protocol.pdf 2026-09-01 10:00:00+0200